Alterity Therapeutics, a company, is based in Melbourne, Australia, and San Francisco, California, USA.
4 reports, 2 independent
Updated Sep 2
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alterity Therapeutics, a company, is based in Melbourne, Australia, and San Francisco, California, USA.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Alterity Therapeutics confirms its base locations in Melbourne and San Francisco.1 source
Ambac Financial Group Inc secured controlling interest in an AI business involving Iglesia de San Francisco.1 source
Keep exploring
The entities involved
-
Melbourne
capital city of Victoria, Australia
-
Iglesia de San Francisco
cultural property in Lorca, Spain
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireAlterity Therapeutics to Present at the Biotech Showcase MELBOURNE, Australia and SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the
- GuruFocus.comAmbac Financial Group Inc (AMBC) Q2 2025 Earnings Call Highlights: Navigating Losses Amid ... Net Loss: $21 million or $0.45 per share, compared to a loss of $15 million or $0.33 per share in Q2 2024
- GlobeNewswireAlterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy – ATH434 Demonstrated Clinical Benefit on the Unified MSA Rating Scale
- Unknown outlet